HOME >> BIOLOGY >> NEWS
Association found between anthrax vaccination, medication and health problems of Gulf War veterans

clined a little bit. We did find that those who recalled that they did receive an anthrax vaccination during the Gulf War, their health deteriorated about twice as fast as folks in similar circumstances who didn't have a recollection of receiving that shot. "

Schumm said researchers also found that many of the medical records or shot records of the veterans had been falsified or destroyed, making it virtually impossible to use clinical data to assess the impact of vaccinations or the pyridostigmine bromide pills. In addition, many veterans reported taking incorrect dosages of the pyridostigmine bromide pills, most taking too few with some taking far too many. Only 24 percent of those reporting their average daily consumption of pills actually took the recommended three pills a day.

"Without actual medical records, it is very difficult to prove causality," Schumm said. "It would be pretty easy to discount any one study by itself as an anomaly since each of the studies have their own unique limitations, but obtaining the same results across different nationalities and research teams would seem to indicate that something went wrong with the process at that time for at least some of the veterans. Personally, I think the best guess is that the mix of pyridostigmine bromide pills, multiple vaccinations in a brief period of time, and high levels of stress combined to adversely affect the health of individuals with genetic susceptibility to such combinations."

Schumm noted that their research confirms results reported previously by British, Canadian, and other U.S. research teams with respect to vaccinations and pyridostigmine bromide consumption. He is working on a critique of a report recently released by the Institute of Medicine, clearing anthrax vaccine of any connection to health problems. Schumm said that it is possible that the anthrax vaccine as given today may be safe while the product as manufactured and administered during the Gulf War i
'"/>

Contact: Walter R. Schumm
wrschumm@k-state.edu
785-532-1494
Kansas State University
3-May-2002


Page: 1 2 3

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. National Corn Growers Association announces valuable maize genome data now available to scientists
3. Highlights of the July Journal of the American Dietetic Association
4. American Lung Associations 2004 State of the Air report ranks cities and counties with dirty air
5. Lunch workshop at the American Association for the Advancement of Science (AAAS) Annual Meeting
6. Highlights of the November 2003 Journal of the American Dietetic Association
7. Highlights of the October 2003 Journal of the American Dietetic Association
8. Mark your calendar for the American Anthropological Association meeting in Chicago Nov. 19-23
9. Applications accepted for research fellowships by the American Association for Cancer Research
10. Funding opportunities for junior faculty offered by the American Association for Cancer Research
11. Nominations sought for professorship by the American Association for Cancer Research

Post Your Comments:
(Date:12/19/2014)...   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ... and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the ... APAC Region 2015-2019"  report to their offering. ... market is advances in technology. With continuous advances ... solutions to the latest standard that meets the ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/24/2014)... December 23, 2014 The ... such as its definition, classification, application and ... specification, manufacturing process, and product cost structure. ... applications. The analysis also covers upstream raw ... industry development trend and proposals. In the ...
(Date:12/24/2014)... BEIJING , Dec. 23, 2014 ... or the "Company"), a leading fully integrated plasma-based ... today announced that its majority-owned subsidiary, Shandong Taibang ... Practices ("GMP") certification from the China Food and ... factor production facility. As previously disclosed in the ...
(Date:12/24/2014)... Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... filed a Clinical Trial Application (CTA) with the ... Agency (MHRA) seeking regulatory approval to initiate clinical trials ... Citrate. Contingent on the Company receiving CTA ... I trial to assess the safety, tolerability and dose ...
(Date:12/22/2014)... RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a ... of autologous cell therapies, announced today the publication of ... conjunction with co-authors from Kyoto University and the University ... clinical research using dermal sheath cup (DSC) cells to ... paper entitled " Hair Follicle Dermal Stem Cells Regenerate ...
Breaking Biology Technology:Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5
Cached News: